The Radice Law Firm Represents direct purchasers in a class action lawsuit filed against dozens of generic drug manufacturers accused of fixing the prices of some 18 different generic drugs. The defendant drug manufacturers raised the prices for each of these drugs at alarming and unprecedented levels, frequently by more than 1,000 percent, and maintained those high prices for years. The case is currently pending before Judge Rufe in the Eastern District of Pennsylvania, who recently issued an Order and Opinion denying the defendants’ joint motion to dismiss the plaintiffs’ overarching conspiracy claims.

Radice Law Firm is one of class counsel for direct purchaser plaintiffs in an antitrust action alleging a scheme by Sanofi to foreclose competition in the market for insulin glargine through improper Orange Book listings of device patents. The case is in discovery in the District of Massachusetts following the First Circuit’s remand in February 2020.

Radice Law Firm is one of class counsel for direct purchaser plaintiffs in an antitrust action alleging an unlawful scheme by Shire and Actavis to monopolize the market for the ADHD medication Intuniv (guanfacine hydrochloride). The case is pending trial in the U.S. District Court for the District of Massachusetts following the court’s denial of Shire’s motions for summary judgment in October 2020.

Radice Law Firm is court-appointed Liaison Counsel for plaintiffs in an antitrust class action alleging that four of the largest distributors of dental supplies and equipment colluded to artificially inflate the prices of dental supplies and equipment.

Radice Law Firm is one of class counsel for plaintiffs in an antitrust class action alleging supra-competitive pricing for DirecTV’s NFL Sunday Ticket service as a result of unlawful exclusive agreements with the NFL.